Rheumatoid Arthritis News

News

Vibex MTX: The Cherry On Top Of The Antares Investment Story - Seeking Alpha
seekingalpha.com | Feb 7, 2012
< strong > By < a href='http://seekingalpha.com/author/smith-on-stocks' > Smith On Stocks < /a > : < /strong > < p > < b > Investment Thesis < /b > < /p > < p > I initiated < a href="http://seekingalpha.com/article/312158-antares-pharmaceuticals-a-buy-based-on-exceptional-new-product-outlook" >

FDA to Review Pfizer Inc Rheumatoid Arthritis Drug
www.biospace.com | Dec 21, 2011
NEW YORK, Dec 20, 2011 -- Pfizer Inc. /quotes/zigman/238207/quotes/nls/pfe PFE +1.04% announced today that the U.S. Food and Drug Administration has

Anti-CCP hs (high sensitive)®: innovative high sensitivity test for diagnosing rheumatoid arthritis
www.prlog.org | Nov 16, 2011
Anti-CCP hs (high sensitive)®: innovative high sensitivity test for diagnosing rheumatoid arthritis. The highly sensitive Anti-CCP hs (high sensitive)® test makes possible the early diagnosis of rheumatoid arthritis (RA), which in turn allows for successful treatment of this autoimmune disease. -

Anti-TNF Therapies May Increase Malignant Melanoma Risks in People with Rheumatoid Arthritis
www.prweb.com | Nov 5, 2011
According to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago, people taking anti-tumor necrosis factor therapies to treat rheumatoid arthritis have a higher risk of developing malignant melanoma.

Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of
www.abbott.com | Nov 2, 2011
Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting

Specialty Pharmaceutical Industry - 2011 Yearbook | SYS-CON MEDIA
www.sys-con.com | Aug 30, 2011
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

Medical News: EULAR: Anti-TNF Drug Use Up Among Indigent RA Patients - in Meeting Coverage, EULAR
www.medpagetoday.com | Jun 1, 2011
LONDON -- The use of biologic anti-tumor necrosis factor drugs by patients under the California Medicaid program has more than tripled since 1999, but utilization of disease-modifying drugs, such as m

New Co-Promotion Agreements for Rheumatoid Arthritis Products in Japan (February 4, 2011) | 2011 |
www.takeda.com | Feb 4, 2011
Pfizer Japan Inc. (“Pfizer,” headquarters: Shibuya-ku, Tokyo) and Takeda Pharmaceutical Company Limited (“Takeda,” headquarters: Chuo-ku, Tokyo) announced today an agreement to extend the period for co-promotion in Japan for the rheumatoid arthritis (RA) drug Enbrel^® (generic name:

Rheumatoid arthritis : The Lancet
www.thelancet.com | Sep 24, 2010
Rheumatoid arthritis. By - Prof David L Scott FRCP, Prof Frederick Wolfe MD, Prof Tom WJ Huizinga MD

A regular tipple may ease rheumatoid arthritis symptoms - Scotsman.com News
news.scotsman.com | Jul 28, 2010
A regular tipple may ease rheumatoid arthritis symptoms - DRINKING alcohol reduces the severity of the symptoms of rheumatoid arthritis, a pioneering new study has revealed.<br />